CosmosID, a leading data mining solutions company for health and wellness, has reported as part of a collaboration results on analysis of labeling claims for the composition of probiotic products ...
COPENHAGEN, Denmark, Jan. 10, 2025 /PRNewswire/ -- Cmbio(R) , a global leader in multi-omics science and digital biology, is pleased to announce the purchase of the e[datascientist](TM) software ...
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avant Technologies, Ainnova Tech, Breakthrough Genomics, Cirrusmd, Clinical Microbiomics, Cmbio ...
COPENHAGEN, Denmark, Nov. 19, 2024 /PRNewswire/ -- Today marks the launch of Cmbio, a new brand that brings together Clinical Microbiomics (Europe), CosmosID (North America), MS-Omics (Europe), ...
Carlsbad, CA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (PALI) (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a ...
Carlsbad, CA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the ...
(MENAFN- PR Newswire) COPENHAGEN, Denmark, Oct. 15, 2024 /PRNewswire/ -- Clinical Microbiomics A/S ("CMC"), a leading innovator in multi-omics, bioinformatics and systems biology for the microbiome ...
Findings demonstrate that the microbiome and enzymes are sufficient in mouse, dog, and Normal Healthy Volunteers (NHV) and Ulcerative Colitis (UC) patients Company advancing toward commencement of ...
Carlsbad, CA, July 29, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback